Breakthrough valve replacement device

The US FDA has just granted Breakthrough Device status to Israel’s PI-Cardia (see here previously) for its ShortCut ™ device that facilitates Transcatheter Aortic Valve Replacement (TAVR) procedures.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *